IL286533A - חומרים ותכשירים לטיפול בדיסקנזיה - Google Patents
חומרים ותכשירים לטיפול בדיסקנזיהInfo
- Publication number
- IL286533A IL286533A IL286533A IL28653321A IL286533A IL 286533 A IL286533 A IL 286533A IL 286533 A IL286533 A IL 286533A IL 28653321 A IL28653321 A IL 28653321A IL 286533 A IL286533 A IL 286533A
- Authority
- IL
- Israel
- Prior art keywords
- adcy5
- compounds
- treatment
- related dyskinesia
- dyskinesia
- Prior art date
Links
- 208000012661 Dyskinesia Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19305366.7A EP3714888A1 (en) | 2019-03-25 | 2019-03-25 | Compounds for use in the treatment of adcy5-related dyskinesia |
| PCT/EP2020/058198 WO2020193567A1 (en) | 2019-03-25 | 2020-03-24 | Compounds for use in the treatment of adcy5-related dyskinesia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL286533A true IL286533A (he) | 2021-10-31 |
Family
ID=66041401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL286533A IL286533A (he) | 2019-03-25 | 2021-09-19 | חומרים ותכשירים לטיפול בדיסקנזיה |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220096486A1 (he) |
| EP (2) | EP3714888A1 (he) |
| AU (1) | AU2020249421A1 (he) |
| CA (1) | CA3134126A1 (he) |
| IL (1) | IL286533A (he) |
| WO (1) | WO2020193567A1 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021210684A1 (ja) * | 2020-04-16 | 2021-10-21 | 協和キリン株式会社 | 運動亢進症治療剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101098209B1 (ko) * | 2002-01-28 | 2011-12-23 | 교와 핫꼬 기린 가부시키가이샤 | 운동성 질환에 걸린 환자의 치료 방법 |
-
2019
- 2019-03-25 EP EP19305366.7A patent/EP3714888A1/en not_active Withdrawn
-
2020
- 2020-03-24 CA CA3134126A patent/CA3134126A1/en active Pending
- 2020-03-24 WO PCT/EP2020/058198 patent/WO2020193567A1/en not_active Ceased
- 2020-03-24 EP EP20712973.5A patent/EP3946353A1/en not_active Withdrawn
- 2020-03-24 AU AU2020249421A patent/AU2020249421A1/en not_active Abandoned
- 2020-03-24 US US17/441,405 patent/US20220096486A1/en not_active Abandoned
-
2021
- 2021-09-19 IL IL286533A patent/IL286533A/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20220096486A1 (en) | 2022-03-31 |
| WO2020193567A1 (en) | 2020-10-01 |
| EP3714888A1 (en) | 2020-09-30 |
| EP3946353A1 (en) | 2022-02-09 |
| AU2020249421A1 (en) | 2021-11-04 |
| CA3134126A1 (en) | 2020-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290415A (he) | תרכובות עם דאוטריום לשימוש בטיפול בסרטן | |
| SG11202000549TA (en) | Mavacamten for use in the treatment of hypertrophic cardiomyopathy | |
| HUE071511T2 (hu) | Elafibranor primer biliáris cirrózis kezelésében történõ alkalmazásra | |
| SI3806898T1 (sl) | Antagonist Gremlin-1 za uporabo pri zdravljenju raka | |
| GB201813876D0 (en) | Treatment | |
| SI3592355T1 (sl) | KX2-391/KX-01 za uporabo pri zdravljenju aktinične keratoze | |
| GB2581876B (en) | Compositions for use in the treatment of endometrial disorder | |
| HUS2400045I1 (hu) | Delgocitinib alkalmazása krónikus kézekcéma kezelésére | |
| GB201800546D0 (en) | Treatment | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| PL3630754T3 (pl) | Związki izoindolinoacetylenowe do leczenia nowotworu | |
| IL286533A (he) | חומרים ותכשירים לטיפול בדיסקנזיה | |
| IL269121A (he) | Usl-311 לשימוש בטיפול בסרטן | |
| SG11202100269VA (en) | Compounds for use in the treatment of fascioliasis | |
| PL3548006T3 (pl) | Kompozycja do stosowania w leczeniu zmian jelitowych | |
| GB201902579D0 (en) | Treatment | |
| HK40074743A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| HK40044464A (en) | R-fadrozole for use in the treatment of aldostonerism | |
| HK40024485A (en) | Composition for use in the treatment of epilepsy | |
| GB201910755D0 (en) | Treatment | |
| GB201901507D0 (en) | New treatment | |
| GB201904253D0 (en) | Treatment | |
| HK40018432A (en) | Usl-311 for use in the treatment of cancer | |
| GB201902578D0 (en) | Treatment | |
| GB201902580D0 (en) | Treatment |